Immuneering Corporation
IMRXNASDAQHealthcare● Active
$4.00
$-0.28(-6.44%)
Market Cap$145027840
P/E Ratio—
52W High$10.08
52W Low$1.66
Immuneering Corporation（IMRX）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · IMRX · 截至 Jun 8, 2026
关键指标
探索 Immuneering Corporation 数据
imrx stock data · financials竞争对手与同行
imrx competitors#TickerCompanyPriceChangeMkt Cap
#1IMRXImmuneering Corporation
$4.00-6.44%$145.0M#2
ARCTArcturus Therapeutics Holdings Inc.
$7.17-2.67%$203.8M#3
ASMBAssembly Biosciences, Inc.
$22.23-1.75%$353.3M#4
ENTAEnanta Pharmaceuticals, Inc.
$10.97-2.16%$254.7M#5
FHTXFoghorn Therapeutics Inc.
$3.64-1.07%$213.7M#6
HUMAHumacyte, Inc.
$1.39+1.85%$232.7M关于 Immuneering Corporation
Immuneering Corporation a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients…
what is immuneering corporation · imrx stock overview · immuneering corporation company profile · who is immuneering corporation ceo · imrx NASDAQ · immuneering corporation headquarters · immuneering corporation business segments
关于股票概览与关键数据
Immuneering Corporation（IMRX）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 30, 2021 在 NASDAQ 上市。截至最近交易日，IMRX 股价为 $4.00，市值约为 $145.0M。过去12个月累计回报 —，年初至今回报 —。
常见问题
截至最近一个交易日，Immuneering Corporation（IMRX）股价为 $4.00，在 NASDAQ 上市，52周区间为 $1.66 – $10.08。
IMRX 最新股价IMRX quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议